ICON (ICLR)
(Delayed Data from NSDQ)
$323.46 USD
+10.36 (3.31%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $326.12 +2.66 (0.82%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
ICON PLC [ICLR]
Reports for Purchase
Showing records 1 - 20 ( 178 total )
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Optimized Entry and Exit Levels for ICLR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Pipeline Build Counters COVID and Funding Risk
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
No Life Science Worries - Positive Reads
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
1Q22 Exceeds with RFPs Showing No Slowdown
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Company: ICON PLC
Industry: Medical Services
Life Science, Bioproduction, CROs: Positive Data Points for 2023
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Major Biopharma Driving Higher Visibility
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ICON PLC
Industry: Medical Services
Transferring Coverage of 5 Companies, Suspending Coverage of 16 Companies, Terminating Coverage of 1 Company
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department